ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

GRCL Gracell Biotechnologies Inc

10.25
0.00 (0.00%)
May 02 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 10.25
Ask Price 10.00
News -
Share Name Share Symbol Market Stock Type
Gracell Biotechnologies Inc GRCL NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 10.25 19:00:00
Open Price Low Price High Price Close Price Previous Close
10.25 10.25
Trades Shares Traded Average Volume
0 0 -
Last Trade Type Quantity Price Currency
- 0  10.25 USD

Gracell Biotechnologies Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 693.92M - - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Gracell Biotechnologies

Date Time Source Heading
3/04/202411:22Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section..
2/27/202423:15Edgar (US Regulatory)Form EFFECT - Notice of Effectiveness
2/26/202416:28Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in..
2/26/202416:28Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration..
2/26/202416:26Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration..
2/26/202416:26Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in..
2/22/202407:50Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/22/202407:45GlobeNewswire Inc.Gracell Biotechnologies Acquisition Completed
2/20/202407:22Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/20/202406:45GlobeNewswire Inc.Gracell Biotechnologies Announces Shareholders’ Approval of..
2/14/202407:20Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
1/30/202405:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No GRCL Message Board. Create One! See More Posts on GRCL Message Board See More Message Board Posts

GRCL Historical

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

Gracell Biotechnologies Inc is a clinical-stage biopharmaceutical company focused on developing and discovering cell and gene therapies to address and fulfill unmet medical needs in the treatment of cancer.

Your Recent History

Delayed Upgrade Clock